Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 1993; 3(2): 226-31.
Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300(5618): 455.
Yoo S, Takikawa S, Geraghty P, et al. Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD. PLoS Genet 2015; 11(1)e1004898
Wippermann A, Rupp O, Brinkrolf K, Hoffrogge R, Noll T. Integrative analysis of DNA methylation and gene expression in butyrate-treated CHO cells. J Biotechnol 2017; 150-61.
Renner M, Wolf T, Meyer H, et al. Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas. Genome Biol 2013; 14(12): r137.
Ramasamy R, Ridgeway A, Lipshultz LI, Lamb DJ. Integrative DNA methylation and gene expression analysis identifies discoidin domain receptor 1 association with idiopathic nonobstructive azoospermiaFertil Steril 2014; 102(4): 968-973 e3.
van Eijk KR, de Jong S, Boks MP, et al. Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics 2012; 13: 636.
Selamat SA, Chung BS, Girard L, et al. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res 2012; 22(7): 1197-211.
Zhang Y, Zhang J, Liu Z, Liu Y, Tuo S. A network-based approach to identify disease-associated gene modules through integrating DNA methylation and gene expression. Biochem Biophys Res Commun 2015; 465(3): 437-42.
Huang D, Ovcharenko I. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia. BMC Genomics 2017; 18(1): 236.
Jiao Y, Widschwendter M, Teschendorff AE. A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control. Bioinformatics 2014; 30(16): 2360-6.
Karsakov A, et al. Parenclitic network analysis of methylation data for Cancer identification. PLoS One 2017; 12(1)e0169661
Wang Z, Curry E, Montana G. Network-guided regression for detecting associations between DNA methylation and gene expression. Bioinformatics 2014; 30(19): 2693-701.
Ma X, Liu Z, Zhang Z, Huang X, Tang W. Multiple network algorithm for epigenetic modules via the integration of genome-wide DNA methylation and gene expression data. BMC Bioinformatics 2017; 18(1): 72.
Wagner JR, Busche S, Ge B, Kwan T, Pastinen T, Blanchette M. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol 2014; 15(2): R37.
Tang B, Wang X. Inferring genome-wide interplay landscape between DNA methylation and transcriptional regulation. Pak J Pharm Sci 2015; 28(1)(Suppl.): 349-52.
Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13(7): 484-92.
Rhee JK, Kim K, Chae H, et al. Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer. Nucleic Acids Res 2013; 41(18): 8464-74.
Moarii M, Boeva V, Vert JP, Reyal F. Changes in correlation between promoter methylation and gene expression in cancer. BMC Genomics 2015; 16(1): 873.
Zhang Y, Zhang J, Shang J. Quantitative identifcation of differentially methylated loci based on relative entropy for matched case-control data. Epigenomics 2013; 5(6): 631-43.
Zaykin DV. Optimally weighted Z-test is a powerful method for combining probabilities in meta-analysis. J Evol Biol 2011; 24(8): 1836-41.
Shen Q, Cheng F, Song H, et al. Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes. Am J Hum Genet 2017; 100(1): 5-20.
Feng L, Jin F. Screening of differentially methylated genes in breast cancer and risk model construction based on TCGA database. Oncol Lett 2018; 16(5): 6407-16.
Jun P, Hong C, Lal A, et al. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Neuro-oncol 2009; 11(4): 414-22.
Fischer K, Pflugfelder GO. Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression. Front Oncol 2015; 5: 244.
Zhang G, He P, Gaedcke J, et al. FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer. Cancer Res 2013; 73(17): 5416-25.
Pathan M, Keerthikumar S, Ang CS, et al. FunRich: An open access standalone functional enrichment and interaction network analysis tool. Proteomics 2015; 15(15): 2597-601.
Mori S, Hatori N, Kawaguchi N, et al. The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis. Biosci Rep 2017; 37(2)Pii BSR20170173
Mori S, Tran V, Nishikawa K, et al. A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesis. PLoS One 2013; 8(2)e57927
Bignone PA, Lee KY, Liu Y, et al. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene 2007; 26(5): 683-700.